The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...
Franklin Lakes-based BD (Becton, Dickinson and Company), a leading global medical technology company, on Tuesday announced plans to invest approximately $1.2 billion over a four-year period to expand ...
Medical Device Network on MSN
BD and Ypsomed develop new version of Neopak XtraFlow syringe
The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.
Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...
Becton Dickinson masterminded the prefillable syringe, and decades later, it's a technology key to the global COVID-19 vaccine rollout. And with pandemic demand surging, BD is planning to shell out $1 ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results